Does LEVOMILNACIPRAN Cause Decreased appetite? 66 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Decreased appetite have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 4.8% of all adverse event reports for LEVOMILNACIPRAN.
66
Reports of Decreased appetite with LEVOMILNACIPRAN
4.8%
of all LEVOMILNACIPRAN reports
56
Deaths
56
Hospitalizations
How Dangerous Is Decreased appetite From LEVOMILNACIPRAN?
Of the 66 reports, 56 (84.8%) resulted in death, 56 (84.8%) required hospitalization, and 55 (83.3%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for LEVOMILNACIPRAN.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which LEVOMILNACIPRAN Alternatives Have Lower Decreased appetite Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE